Ancora Advisors’s Avanos Medical AVNS Stock Holding History

Ancora Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19	Closed	-$378	–	1840
2024 Q1	$378	Hold	19	–	–	﹤0.01%	1696
2023 Q4	$426	Hold	19	–	–	﹤0.01%	1609
2023 Q3	$384	Hold	19	–	–	﹤0.01%	1645
2023 Q2	$486	Hold	19	–	–	﹤0.01%	1634
2023 Q1	$565	Hold	19	–	–	﹤0.01%	1710
2022 Q4	$1K	Sell	19 -62	-77%	-$1.52K	﹤0.01%	1654
2022 Q3	$2K	Hold	81	–	–	﹤0.01%	1771
2022 Q2	$2K	Hold	81	–	–	﹤0.01%	1927
2022 Q1	$3K	Buy	+81	New	+$2.61K	﹤0.01%	2060
2017 Q1	–	Sell	-283	Closed	-$11K	–	641
2016 Q4	$11K	Buy	+283	New	+$10.1K	﹤0.01%	1028
2016 Q1	–	Sell	-52,181	Closed	-$1.74M	–	497
2015 Q4	$1.74M	Sell	52,181 -3,274	-6%	-$102K	0.22%	125
2015 Q3	$1.58M	Sell	55,455 -23,390	-30%	-$816K	0.2%	135
2015 Q2	$3.19M	Buy	+78,845	New	+$3.54M	0.38%	71
2015 Q1	–	Sell	-39,914	Closed	-$1.85M	–	94
2014 Q4	$1.81M	Buy	+39,914	New	+$1.57M	0.22%	122

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Ancora Advisors's AVNS Position: Q2 2024 in Review

Ancora Advisors sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 19 shares — an estimated $378 sold.

Ancora Advisors first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $3.19M in Q2 2015. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

Ancora Advisors reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
Ancora Advisors sold 19 Avanos Medical shares in Q2 2024, an estimated $378.
Ancora Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
Ancora Advisors's Avanos Medical position peaked at $3.19M in Q2 2015.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Ancora Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.